Search
Search
About
Log in
Join
Experiences with
Nivolumab
Posts
Communities
118 public posts
Filter results
XB0002-101 trial ( jewel??)
It would be the solo drug for me, not the other arms of the trial which includes avastin and
nivolumab
in conjunction with trial drug. Thanks
It would be the solo drug for me, not the other arms of the trial which includes avastin and
nivolumab
in conjunction with trial drug. Thanks
Laz66
in
My Ovacome
3 months ago
BAT & Nivolumab
-Patrick [1] https://pubmed.ncbi.nlm.nih.gov/38167882/ [2] https://en.wikipedia.org/wiki/
Nivolumab
-Patrick [1] https://pubmed.ncbi.nlm.nih.gov/38167882/ [2] https://en.wikipedia.org/wiki/
Nivolumab
pca2004
in
Fight Prostate Cancer
5 months ago
#AskChatGPT : list of immunotherapy drugs for prostate cancer
Nivolumab
(Opdivo):
Nivolumab
is another checkpoint inhibitor that targets PD-1. Like pembrolizumab,
nivolumab
has been studied in clinical trials for advanced prostate cancer, often in combination with other therapies.
Nivolumab
(Opdivo):
Nivolumab
is another checkpoint inhibitor that targets PD-1. Like pembrolizumab,
nivolumab
has been studied in clinical trials for advanced prostate cancer, often in combination with other therapies.
God_Loves_Me
in
Advanced Prostate Cancer
17 days ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
LIQUID BIOPSY: Hello friends, what do you know about Liquid biopsy of circulating tumor ctDNA? Is it usefull with 6.2 PSA ?
Depending on the results do we get access to some novel drugs like olapariv or
nivolumab
, etc, that might help us ? 🫠thanks, Manilo.
Depending on the results do we get access to some novel drugs like olapariv or
nivolumab
, etc, that might help us ? 🫠thanks, Manilo.
Manilo
in
Advanced Prostate Cancer
4 months ago
CDK 12 mutation and Immunotherapy
I also found an ongoing trial immunotherapy trial IMPACT (NCT03570619) which combines other drugs used for immunotherapy with CDK12 (ie:
Nivolumab
and Ipilimumab) Has anyone here in the community had success on either of these trials?
I also found an ongoing trial immunotherapy trial IMPACT (NCT03570619) which combines other drugs used for immunotherapy with CDK12 (ie:
Nivolumab
and Ipilimumab) Has anyone here in the community had success on either of these trials?
MikeMartin
in
Advanced Prostate Cancer
4 months ago
PATIENT EXPERIENCE OF NIVOLUMAB
NIVOLUMAB
will shortly be assessed by the Scottish Medicine Consortium (SMC) for use in NHS Scotland in combination with platinum-based chemotherapy for the neoadjuvant treatment (this is treatment given before surgery) for resectable non-small cell lung cancer in adults.
NIVOLUMAB
will shortly be assessed by the Scottish Medicine Consortium (SMC) for use in NHS Scotland in combination with platinum-based chemotherapy for the neoadjuvant treatment (this is treatment given before surgery) for resectable non-small cell lung cancer in adults.
RoyCastleHelpline
Roy Castle
in
The Roy Castle Lung Cancer Foundation
9 months ago
I like it, but not too much: Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with nmHSPC
"No patients met the primary endpoint of complete PSA response; however, 4/19 (21%) patients had a PSA decline >50%. Median PSA doubling times were 5.9 months pretreatment, 25.6 months on-treatment (p=0.001), and 9.0 months in the subsequent year off-treatment. The overall median radiographic progression-free
"No patients met the primary endpoint of complete PSA response; however, 4/19 (21%) patients had a PSA decline >50%. Median PSA doubling times were 5.9 months pretreatment, 25.6 months on-treatment (p=0.001), and 9.0 months in the subsequent year off-treatment. The overall median radiographic progression-free
Maxone73
in
Advanced Prostate Cancer
5 months ago
PATIENT EXPERIENCE OF ADJUVANT CHEMOTHERAPY AFTER SURGERY
NIVOLUMAB
will shortly be assessed by the Scottish Medicine Consortium (SMC) for use in NHS Scotland in combination with platinum-based chemotherapy for the neoadjuvant (treatment given before surgery) for resectable non-small cell lung cancer in adults.
NIVOLUMAB
will shortly be assessed by the Scottish Medicine Consortium (SMC) for use in NHS Scotland in combination with platinum-based chemotherapy for the neoadjuvant (treatment given before surgery) for resectable non-small cell lung cancer in adults.
RoyCastleHelpline
Roy Castle
in
The Roy Castle Lung Cancer Foundation
9 months ago
KRAS G13D
The new plan is to combination of dual immunotherapy with two immunotherapy drugs
nivolumab
and ipilimumab. Has anyone gone through a similar journey when 1st line treatment didn't work and pivoted?
The new plan is to combination of dual immunotherapy with two immunotherapy drugs
nivolumab
and ipilimumab. Has anyone gone through a similar journey when 1st line treatment didn't work and pivoted?
CuteLabrador123
in
Lung Cancer Support
1 year ago
Research on melanoma treatment
https://www.mdanderson.org/newsroom/neoadjuvant-immunotherapy-with-relatlimab-and-
nivolumab
-is-safe-and-effective-in-stage-3-melanoma.h00-159543690.html Nature link from article: https://www.nature.com/articles/s41586-022-05368-8
https://www.mdanderson.org/newsroom/neoadjuvant-immunotherapy-with-relatlimab-and-
nivolumab
-is-safe-and-effective-in-stage-3-melanoma.h00-159543690.html Nature link from article: https://www.nature.com/articles/s41586-022-05368-8
Rando21
in
CLL Support
2 years ago
Severe reaction to immunotherapy
Hi My husband has mesothelioma and has been having immunotherapy (Ipilimumab and
Nivolumab
) every 3 weeks since early January this year.
Hi My husband has mesothelioma and has been having immunotherapy (Ipilimumab and
Nivolumab
) every 3 weeks since early January this year.
toffeepudding
in
The Roy Castle Lung Cancer Foundation
1 year ago
Results from Phase 2 study of nivolumab plus ibrutinib in patients with diffuse large b-cell Richter Transformation of CLL
This research is based on a hypothesis that asks "[i]if combining
nivolumab
, a PD-1 blocking antibody, with the BTK inhibitor (BTKi) ibrutinib could potentiate tumor-cell killing."[/i] [i]"Patients received
nivolumab
every 2 weeks of a 4-week cycle for a maximum of 24 cycles.
This research is based on a hypothesis that asks "[i]if combining
nivolumab
, a PD-1 blocking antibody, with the BTK inhibitor (BTKi) ibrutinib could potentiate tumor-cell killing."[/i] [i]"Patients received
nivolumab
every 2 weeks of a 4-week cycle for a maximum of 24 cycles.
CLLerinOz
Volunteer
in
CLL Support
2 years ago
Cellular and Genetic Clues that Drive BAT effectiveness
Then added immune checkpoint inhibitor
nivolumab
. Since BAT causes DNA damage and genomic rearrangements, they wanted to see if the
nivolumab
, as an immune therapy (PD-1 inhibitor) might add to the efficacy of BAT.
Then added immune checkpoint inhibitor
nivolumab
. Since BAT causes DNA damage and genomic rearrangements, they wanted to see if the
nivolumab
, as an immune therapy (PD-1 inhibitor) might add to the efficacy of BAT.
MateoBeach
in
Advanced Prostate Cancer
2 years ago
EVOLUTION - Trial for the treatment of mCRPC
The purpose of the EVOLUTION trial involving 100 patients is to see if combining two drugs ipilimumab and
nivolumab
, which activate the body's own immune system, with Lu-PSMA can further improve anti-cancer effects of Lu-PSMA.
The purpose of the EVOLUTION trial involving 100 patients is to see if combining two drugs ipilimumab and
nivolumab
, which activate the body's own immune system, with Lu-PSMA can further improve anti-cancer effects of Lu-PSMA.
marnieg46
in
Advanced Prostate Cancer
2 years ago
Latest from BATman Denmeade
These include BAT in combination with the immunotherapy
Nivolumab
(Opdivo) (NCT03554317), the DNA-repair inhibitor olaparib (Lynparza) (NCT03516812), the bone targeted radiation therapy 223Radium (Xofigo) (NCT04704505), and the DNA-damaging drug carboplatin (NCT03522064). 3 CONCLUSIONS The key findings
These include BAT in combination with the immunotherapy
Nivolumab
(Opdivo) (NCT03554317), the DNA-repair inhibitor olaparib (Lynparza) (NCT03516812), the bone targeted radiation therapy 223Radium (Xofigo) (NCT04704505), and the DNA-damaging drug carboplatin (NCT03522064). 3 CONCLUSIONS The key findings
pjoshea13
in
Advanced Prostate Cancer
2 years ago
FDA Approves New Combination Treatment Using Immunotherapy Before Surgery for Early-Stage NSCLC
On March 4th, 2022, the Food and Drug Administration (FDA) approved Opdivo (
nivolumab
) for treatment before surgery in combination with platinum-based chemotherapy in patients with stage IB to IIIA non-small cell lung cancer (NSCLC).
On March 4th, 2022, the Food and Drug Administration (FDA) approved Opdivo (
nivolumab
) for treatment before surgery in combination with platinum-based chemotherapy in patients with stage IB to IIIA non-small cell lung cancer (NSCLC).
Miranda_GO2
Partner
in
Lung Cancer Support
2 years ago
Nivolumab+docetaxel trial
My MO suggested me to participate in
Nivolumab
/placebo + docetaxel trial, Phase 3. I checked the results of Phase 2, and, honestly, I was not very impressed with results. I found no big difference between effectiveness of this combo and docetaxel only.
My MO suggested me to participate in
Nivolumab
/placebo + docetaxel trial, Phase 3. I checked the results of Phase 2, and, honestly, I was not very impressed with results. I found no big difference between effectiveness of this combo and docetaxel only.
Catfish21
in
Advanced Prostate Cancer
2 years ago
Study participation
I've been asked to participate in a study for a drug called
Nivolumab
. It's done in conjunction with chemotherapy. I was given a 35 page document explaining the test and the side effects of which there are many.
I've been asked to participate in a study for a drug called
Nivolumab
. It's done in conjunction with chemotherapy. I was given a 35 page document explaining the test and the side effects of which there are many.
Misanthrope12
in
Advanced Prostate Cancer
3 years ago
Naming our drugs-how does that happen?
One kind soul used that to explain how -mab described a monoclonal antibody (think
Nivolumab
/Opdivo). He went on to teach me that the suffix -nib means the drug is an inhibitor like afatnib which is used as a TKI inhibitor(also know as Gilotrif). So today I read this blog about naming drugs.
One kind soul used that to explain how -mab described a monoclonal antibody (think
Nivolumab
/Opdivo). He went on to teach me that the suffix -nib means the drug is an inhibitor like afatnib which is used as a TKI inhibitor(also know as Gilotrif). So today I read this blog about naming drugs.
Denzie
Volunteer
in
Lung Cancer Support
2 years ago
Is this news to anybody?
A new treatment for terminal head and neck cancer patients - combining two immunotherapy drugs,
nivolumab
and ipilimumab. The CheckMate 651 trial, funded by Bristol Myers Squibb - showed especially good results in tumors with high levels of a marker called PD-L1.
A new treatment for terminal head and neck cancer patients - combining two immunotherapy drugs,
nivolumab
and ipilimumab. The CheckMate 651 trial, funded by Bristol Myers Squibb - showed especially good results in tumors with high levels of a marker called PD-L1.
kapakahi
in
Advanced Prostate Cancer
3 years ago
1
2
...
6
Next page
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
47 results
The Roy Castle Lung Cancer Foundation
19 results
Lung Cancer Support
12 results
View top 10 communities
Sort by
Most Relevant
Newest